Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13518198 | 0.88 | EPHX2 (0.39) | EPHX2PRKCAPRKCDALDH1A1CNR1 | |
| SCHEMBL13822647 | 0.83 | EPHX2 (0.34) | EPHX2PRKCAPRKCD | |
| SCHEMBL13822595 | 0.82 | EPHX2 (0.35) | EPHX2PRKCAPRKCDCNR1DAGLA | |
| SCHEMBL13822572 | 0.81 | EPHX2 (0.36) | EPHX2PRKCAPRKCDCNR1DAGLA | |
| SCHEMBL13822570 | 0.81 | POLB (0.47) | RAB9AEPHX2PRKCAPRKCDALDH1A1 | |
| SCHEMBL30272012 | 0.81 | EPHX2 (0.47) | EPHX2PRKCAPRKCDCNR1DAGLA | |
| SCHEMBL13822458 | 0.80 | EPHX2 (0.35) | EPHX2PRKCAPRKCDCNR1DAGLA | |
| SCHEMBL13822509 | 0.80 | EPHX2 (0.38) | EPHX2PRKCAPRKCDCNR1DAGLA | |
| SCHEMBL13822551 | 0.75 | PRKCA (0.34) | EPHX2PRKCAPRKCDCNR1DAGLA | |
| SCHEMBL7719860 | 0.75 | EPHX2 (0.39) | EPHX2PRKCAPRKCDCNR1DAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10308563-B2 | Process for producing ethylene oligomers | HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) | 2019-06-04 | — | — | US | disclosed |
| EP-2524930-B1 | PREPARATION METHOD OF SOLID CATALYST FOR PROPYLENE POLYMERIZATION, AND CATALYST PREPARED THEREBY | HANWHA TOTAL PETROCHEMICAL CO LTD (KR) | 2018-09-12 | — | — | EP | disclosed |
| US-20180170827-A1 | PROCESS FOR PRODUCING ETHYLENE OLIGOMERS | HANWHA TOTALENERGIES PETROCHEMICAL CO., LTD. (KR) | 2018-06-21 | — | — | US | disclosed |
| US-20180169642-A1 | CATALYST SYSTEM FOR ETHYLENE OLIGOMERIZATION AND METHOD FOR PRODUCING ETHYLENE OLIGOMERIZATION USING THE SAME | HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) | 2018-06-21 | — | — | US | disclosed |
| US-9045572-B2 | Preparation method of solid catalyst for propylene polymerization and catalyst prepared thereby | SAMSUNG TOTAL PETROCHEMICALS CO., LTD. (KR) | 2015-06-02 | — | — | US | disclosed |
| US-20140005345-A1 | SOLID CATALYST FOR PROPYLENE POLYMERIZATION AND A METHOD FOR PREPARATION OF POLYPROPYLENE | HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) | 2014-01-02 | — | — | US | disclosed |
| US-20130017946-A1 | PREPARATION METHOD OF SOLID CATALYST FOR PROPYLENE POLYMERIZATION AND CATALYST PREPARED THEREBY | SAMSUNG TOTAL PETROCHEMICALS CO., LTD. (KR) | 2013-01-17 | — | — | US | disclosed |
| EP-2524930-A2 | PREPARATION METHOD OF SOLID CATALYST FOR PROPYLENE POLYMERIZATION, AND CATALYST PREPARED THEREBY | Samsung Total Petrochemicals Co. Ltd. (KR) | 2012-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308563-B2 | Process for producing ethylene oligomers | OXER1, HAO2, ORC3 | NPC1 1536/4885RAB9A 3258/4885EPHX2 27/4885 |
| US-20180169642-A1 | CATALYST SYSTEM FOR ETHYLENE OLIGOMERIZATION AND METHOD FOR PRODUCING ETHYLENE OLIGOMERIZATION USING THE SAME | HACL2, HAO2, MSMO1 | NPC1 1894/4885RAB9A 3554/4885EPHX2 17/4885 |
| US-20180170827-A1 | PROCESS FOR PRODUCING ETHYLENE OLIGOMERS | OXER1, HAO2, ORC3 | NPC1 1536/4885RAB9A 3258/4885EPHX2 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.